CTSO
Cytosorbents Corp

2,140
Mkt Cap
$41.45M
Volume
224,167.00
52W High
$1.39
52W Low
$0.60
PE Ratio
-3.47
CTSO Fundamentals
Price
$0.66
Prev Close
$0.638
Open
$0.62
50D MA
$0.6918
Beta
0.74
Avg. Volume
70,493.14
EPS (Annual)
-$0.3806
P/B
4.59
Rev/Employee
$238,889.40
$68.15
Loading...
Loading...
News
all
press releases
CytoSorbents Announces HotSwap Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026
CytoSorbents Announces HotSwap Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026 CytoSorbents Announces HotSwap Launch, Renewed Aferetica Partnership, and New Clinical...
PR Newswire·3d ago
News Placeholder
More News
News Placeholder
CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent...
PR Newswire·17d ago
News Placeholder
What Analysts Are Saying About CytoSorbents Stock
read more...
Benzinga·2mo ago
News Placeholder
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and...
PR Newswire·2mo ago
News Placeholder
CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025
CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025 CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday...
PR Newswire·3mo ago
News Placeholder
Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London
Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London PR Newswire...
PR Newswire·4mo ago
News Placeholder
CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update
CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update PR Newswire PRINCETON...
PR Newswire·4mo ago
News Placeholder
CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London
CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London PR Newswire PRINCETON, N.J...
PR Newswire·4mo ago
News Placeholder
CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights
CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights PR Newswire...
PR Newswire·5mo ago
News Placeholder
In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer
In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer In Memoriam: Dr. Robert Hawes Bartlett...
PR Newswire·5mo ago
<
1
2
...
>

Latest CTSO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.